The global Tracleer bosentan market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Tracleer bosentan drug is an endothelin receptor antagonist that helps to decrease blood pressure in the lungs and is also used to treat pulmonary arterial hypertension. This drug works by blocking the endothelin-1 that helps in lowering the blood pressure in the lungs and helps to improve the ability to exercise. The global Tracleer bosentan drug market is increasing due to the increasing prevalence of pulmonary arterial hypertension across the globe. According to National Organization for Rare Disorders, pulmonary arterial hypertension is 3-5 times more prevalent in females than males. The age group of the females diagnosed with pulmonary arterial hypertension is between 30-60 years.
(Get 15% Discount on Buying this Report)
A full report is available at : https://orionmarketreports.com/global-tracleer-bosentan/92757/
For instance, In June 2019, Teva Pharmaceutical Industries Ltd. announced their launch of the generic version of Tracleer bosentan tablets in the US market. It will be available in 62.5 mg and 125 mg variants in the US market. In September 207, US Food and Drug Administration approved the paediatric version of pulmonary arterial hypertension drug for children aged 3years and older. In June 2019, NATCO Pharma Ltd. announced their submission of abbreviated New Drug Application with Para IV certification with the U.S. Food and Drug Administration for the generic version of Tracleer bosentan tablets. It is available in a 32mg tablet variant for oral administration. In June 2019, Hikma Pharmaceuticals PLC announced their launch of Tracleer bosentan tablets in the global market in 62.5mg and 125mg variants.
Market Coverage
The market number available for – 2022-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
By Distribution Channel
Regions Covered-
- North America
- Europe
- Asia-Pacific
Rest of the World
Competitive Landscape– Teva Pharmaceutical Industries Ltd., NATCO Pharma Ltd., Johnson & Johnson Services, Inc. among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How are playersaddressing challenges to sustain growth?
- Where is the investment opportunity?
Global Tracleer Bosentan Market Report by Segment
By Type
- 32 mg Tablet
- 5 mg Tablet
- 125 mg Tablet
By Application
- Children
- Adults
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name : Orion Market Reports
Contact Person : Mr. Anurag Tiwari
Email : Info@orionmarketreports.com
Contact No : +91 780-304-0404
This release has been published on omrindustryjournal Market Post.
omrindustryjournal Market Post is not responsible for any content included in this release.
